The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease

• Conditions: Connective Tissue Disease; Interstitial Lung Disease; Idiopathic Pulmonary Fibrosis

• Registration Number: NCT01809574
• Lead Sponsor: Meir Medical Center

Brief Summary

We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to improved outcomes.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-03-10
• Study First Submitted QC: 2013-03-11
• Study First Posted: 2013-03-12
• Study Start: 2013-05
• Status Verified: 2013-10
• Last Update Submitted: 2015-04-08
• Last Update Posted: 2015-04-09
• Primary Completion: 2016-03
• Study Completion: 2016-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Age above 18 years old
• ILD according to ATS/ERS guidelines
• Signed inform consent

Exclusion Criteria

• Previous lung surgery
• Other significant systemic disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The number of patients with collagen related pulmonary fibrosis that are diagnosed by Rheumatologists compared to Pulmonologists.	two years

Trial Locations

Locations (1)

Meir Medical Center; 🇮🇱 Kfar Saba, Israel